Cargando…

Analysis of Plasma Concentrations of Theophylline in Smoking and Nonsmoking Patients with Asthma

BACKGROUND: While dosing theophylline in asthmatics, we should consider that a lot of medicines, substances, conditions and diseases affect the clearance of theophylline, such as smoking, macrolide antibiotics, barbiturates, oral contraceptives, heart and liver insufficiency, alcohol, calcium-antago...

Descripción completa

Detalles Bibliográficos
Autores principales: Goseva, Zlatica, Gjorcev, Angelko, Kaeva, Biserka Jovkovska, Janeva, Elena Jovanovska, Angelovska, Irina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Institute of Immunobiology and Human Genetics 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877906/
https://www.ncbi.nlm.nih.gov/pubmed/27275306
http://dx.doi.org/10.3889/oamjms.2015.117
_version_ 1782433474667347968
author Goseva, Zlatica
Gjorcev, Angelko
Kaeva, Biserka Jovkovska
Janeva, Elena Jovanovska
Angelovska, Irina
author_facet Goseva, Zlatica
Gjorcev, Angelko
Kaeva, Biserka Jovkovska
Janeva, Elena Jovanovska
Angelovska, Irina
author_sort Goseva, Zlatica
collection PubMed
description BACKGROUND: While dosing theophylline in asthmatics, we should consider that a lot of medicines, substances, conditions and diseases affect the clearance of theophylline, such as smoking, macrolide antibiotics, barbiturates, oral contraceptives, heart and liver insufficiency, alcohol, calcium-antagonists, pneumonia, viral infections, hypoxemia, etc. AIM: The aim of the study is to investigate the concentrations of theophylline during the day in smoking and nonsmoking patients with asthma. MATERIAL AND METHODS: We have estimated the concentrations of theophylline 6 times daily by the HPLC method (Keith Muir, J Chromatography) in 20 smoking and 20 nonsmoking asthmatic patients, who were treated with theophylline sustained-release tablets 175 mg twice daily. RESULTS: In the first group of 20 nonsmoking patients we obtained constant therapeutic and optimal concentrations of theophylline. In the second group of 20 smoking asthmatics the concentration of theophylline in plasma, in 8pm and 8am the next day was very low. CONCLUSION: Because in smokers we have increased clearance and the decreased half- life of theophylline, and in order to prevent the night time life-threatening attacks, it is necessary to recommend maximal doses of theophylline, especially in the evening. According to the study, dosage should be individualized in order to optimize the treatment based on the measurement of theophylline concentration in plasma.
format Online
Article
Text
id pubmed-4877906
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Institute of Immunobiology and Human Genetics
record_format MEDLINE/PubMed
spelling pubmed-48779062016-06-06 Analysis of Plasma Concentrations of Theophylline in Smoking and Nonsmoking Patients with Asthma Goseva, Zlatica Gjorcev, Angelko Kaeva, Biserka Jovkovska Janeva, Elena Jovanovska Angelovska, Irina Open Access Maced J Med Sci Clinical Science BACKGROUND: While dosing theophylline in asthmatics, we should consider that a lot of medicines, substances, conditions and diseases affect the clearance of theophylline, such as smoking, macrolide antibiotics, barbiturates, oral contraceptives, heart and liver insufficiency, alcohol, calcium-antagonists, pneumonia, viral infections, hypoxemia, etc. AIM: The aim of the study is to investigate the concentrations of theophylline during the day in smoking and nonsmoking patients with asthma. MATERIAL AND METHODS: We have estimated the concentrations of theophylline 6 times daily by the HPLC method (Keith Muir, J Chromatography) in 20 smoking and 20 nonsmoking asthmatic patients, who were treated with theophylline sustained-release tablets 175 mg twice daily. RESULTS: In the first group of 20 nonsmoking patients we obtained constant therapeutic and optimal concentrations of theophylline. In the second group of 20 smoking asthmatics the concentration of theophylline in plasma, in 8pm and 8am the next day was very low. CONCLUSION: Because in smokers we have increased clearance and the decreased half- life of theophylline, and in order to prevent the night time life-threatening attacks, it is necessary to recommend maximal doses of theophylline, especially in the evening. According to the study, dosage should be individualized in order to optimize the treatment based on the measurement of theophylline concentration in plasma. Institute of Immunobiology and Human Genetics 2015-12-15 2015-11-14 /pmc/articles/PMC4877906/ /pubmed/27275306 http://dx.doi.org/10.3889/oamjms.2015.117 Text en Copyright: © 2015 Zlatica Goseva, Angelko Gjorcev, Biserka Jovkovska Kaeva, Elena Jovanovska Janeva, Irina Angelovska. http://creativecommons.org/licenses/by/2.5/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Clinical Science
Goseva, Zlatica
Gjorcev, Angelko
Kaeva, Biserka Jovkovska
Janeva, Elena Jovanovska
Angelovska, Irina
Analysis of Plasma Concentrations of Theophylline in Smoking and Nonsmoking Patients with Asthma
title Analysis of Plasma Concentrations of Theophylline in Smoking and Nonsmoking Patients with Asthma
title_full Analysis of Plasma Concentrations of Theophylline in Smoking and Nonsmoking Patients with Asthma
title_fullStr Analysis of Plasma Concentrations of Theophylline in Smoking and Nonsmoking Patients with Asthma
title_full_unstemmed Analysis of Plasma Concentrations of Theophylline in Smoking and Nonsmoking Patients with Asthma
title_short Analysis of Plasma Concentrations of Theophylline in Smoking and Nonsmoking Patients with Asthma
title_sort analysis of plasma concentrations of theophylline in smoking and nonsmoking patients with asthma
topic Clinical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877906/
https://www.ncbi.nlm.nih.gov/pubmed/27275306
http://dx.doi.org/10.3889/oamjms.2015.117
work_keys_str_mv AT gosevazlatica analysisofplasmaconcentrationsoftheophyllineinsmokingandnonsmokingpatientswithasthma
AT gjorcevangelko analysisofplasmaconcentrationsoftheophyllineinsmokingandnonsmokingpatientswithasthma
AT kaevabiserkajovkovska analysisofplasmaconcentrationsoftheophyllineinsmokingandnonsmokingpatientswithasthma
AT janevaelenajovanovska analysisofplasmaconcentrationsoftheophyllineinsmokingandnonsmokingpatientswithasthma
AT angelovskairina analysisofplasmaconcentrationsoftheophyllineinsmokingandnonsmokingpatientswithasthma